Azitra Inc (AZTR) Stock Price

AZTRStock

$0.07−89.69%52W

Market Cap$4.33M

P/E—

PEG Ratio—

Div yield—

Beta-0.90

AZTR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-83.89%

Price vs S&P 500 (4W)-59.15%

VGM Score11.92

Book Value / Share (Quarterly)$0.12

P/TBV (Annual)0.82x

Revenue Growth (3Y)-59.15%

Cash Flow / Share (Quarterly)$-0.18

Price vs S&P 500 (YTD)-87.09%

Net Profit Margin (TTM)-1721.97%

EPS (TTM)$-2.06

10-Day Avg Trading Volume0.80M

EPS Excl Extra (TTM)$-2.06

EPS (Annual)$-2.25

ROI (Annual)-273.18%

Net Profit Margin (5Y Avg)-26947.34%

Cash / Share (Quarterly)$0.11

ROA (Last FY)-218.00%

EBITD / Share (TTM)$-1.33

ROE (5Y Avg)-197.36%

Operating Margin (TTM)-1772.18%

Cash Flow / Share (Annual)$-1.05

P/B Ratio0.59x

P/B Ratio (Quarterly)0.37x

Net Income / Employee (Annual)$-842,700

EV / Revenue (TTM)-5.86x

Net Interest Coverage (TTM)-66.81x

ROA (TTM)-178.15%

EPS Incl Extra (Annual)$-2.25

Current Ratio (Annual)2.83x

Quick Ratio (Quarterly)4.49x

3-Month Avg Trading Volume8.89M

52-Week Price Return-89.69%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.12

P/S Ratio (Annual)577.76x

Asset Turnover (Annual)0.00x

52-Week High$1.09

Operating Margin (5Y Avg)-32140.94%

EPS Excl Extra (Annual)$-2.25

CapEx CAGR (5Y)-35.68%

26-Week Price Return-69.46%

Quick Ratio (Annual)2.07x

13-Week Price Return-44.44%

Total Debt / Equity (Annual)0.06x

Current Ratio (Quarterly)4.86x

Enterprise Value$-2.39M

Asset Turnover (TTM)0.07x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-119446.13%

Cash / Share (Annual)$0.19

3-Month Return Std Dev111.39%

Net Income / Employee (TTM)$-606,700

ROE (Last FY)-288.21%

Net Interest Coverage (Annual)-66.64x

EPS Basic Excl Extra (Annual)$-2.25

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-2.06

Receivables Turnover (Annual)0.00x

ROI (TTM)-267.46%

P/S Ratio (TTM)10.62x

Pretax Margin (5Y Avg)-26922.75%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.32

Price vs S&P 500 (52W)-107.03%

Year-to-Date Return-73.00%

5-Day Price Return-45.83%

EPS Normalized (Annual)$-2.25

ROA (5Y Avg)-159.41%

Net Profit Margin (Annual)-119566.53%

Month-to-Date Return-48.04%

Cash Flow / Share (TTM)$-1.76

EBITD / Share (Annual)$-2.22

Operating Margin (Annual)-146468.53%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-190.52%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-2.06

P/TBV (Quarterly)0.39x

P/B Ratio (Annual)0.75x

Pretax Margin (TTM)-1717.73%

Book Value / Share (Annual)$0.35

Price vs S&P 500 (13W)-47.93%

Beta-0.90x

Revenue / Share (TTM)$0.00

ROE (TTM)-284.75%

52-Week Low$0.05

mGradeF

vgmGradeF

AZTR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 12, 2026	-$0.23	-$0.17	+24.44%(+$0.05)
Q1 2026	May 13, 2026	-$0.04	-$0.25	-525.00%(-$0.21)
Q4 2025	Feb 27, 2026	-$0.33	-$1.17	-260.00%(-$0.85)
Q3 2025	Nov 12, 2025	-$0.78	-$0.67	+13.55%(+$0.10)
Q2 2025	Aug 11, 2025	-$1.40	-$1.20	+14.29%(+$0.20)

AZTR Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
AZTRAzitra Inc	—	—	F	10.6x	—	—	—	$0.07
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Azitra Inc

Azitra Inc is a clinical-stage biopharmaceutical company developing engineered microbial and protein therapeutics for rare dermatological diseases. Its proprietary platform identifies and genetically engineers naturally occurring bacteria to create live biotherapeutics, recombinant proteins, and small molecules for precision skin disease treatment. The company's pipeline includes ATR-12 for Netherton syndrome, ATR-04 for papulopustular rash, and ATR-01 for ichthyosis vulgaris.